Single-use Bioprocessing Market to reach USD 100.9 Billion by 2032, growing at a CAGR of 15.9%

Technological advancements, rising biologics demand, and government support are the factors behind the massive growth of the Single-use Bioprocessing Market. Biopharmaceuticals and biologics are becoming critical sectors for owned healthcare in multiple regions, and governments have begun to respond by investing in bioprocessing technologies. For example, in the United States, the NIH and BARDA have ramped up funding of biotechnology innovations. In 2023, NIH set aside an estimated $45 billion for medical research funding, which includes a significant amount for bioprocessing and drug development technologies like single-use systems. To contribute to this, an increased commitment has been made evident; it has helped create an environment that is widening the scope of the single-use bioprocessing market, which is perceived as a more feasible choice based on its cost-effectiveness, flexibility, and scalability over conventional stainless-steel systems.